Stock Options

Quote
Anonymous said:
Please give examples of launch failures....I'm not trying to argue just curious.
Click to expand...

You're joking right? All you have to do is go on pharmaceutical news websites like fiercepharma and you will see tons of unsuccessful launches, tons of drugs not getting FDA approval etc. This isn't a sure thing and welcome to big Pharma.
 






Anonymous said:
You're joking right? All you have to do is go on pharmaceutical news websites like fiercepharma and you will see tons of unsuccessful launches, tons of drugs not getting FDA approval etc. This isn't a sure thing and welcome to big Pharma.
Click to expand...



I thought you meant there were many launch failures WITHIN Regeneron, not all companies. Let's face it. There aren't many places to go these days. Most opportunities are a significant risk and you're only as good as 1.) coverage and 2.) Your manager's subjective opinion of you.This isn't the best opp out there but what is?
 












Benefits:

Did anyone read through the benefits carefully and find the STD and LTD benefits bizarre? I've never paid attention to it in the past because I have not needed it and it was free. The way it reads is that you are charged for it here if you want your salary to be protected, otherwise you will be left without income if something happens to you like an accident or something??? Someone please help me understand this?? It also reads like you must be there for a year to have income "protection." Really?
 












Anonymous said:
Benefits:

Did anyone read through the benefits carefully and find the STD and LTD benefits bizarre? I've never paid attention to it in the past because I have not needed it and it was free. The way it reads is that you are charged for it here if you want your salary to be protected, otherwise you will be left without income if something happens to you like an accident or something??? Someone please help me understand this?? It also reads like you must be there for a year to have income "protection." Really?
Click to expand...

Good Catch
 






Why so much negativity? Even "low" pay in this business is top 10% of incomes across the country. Being overpaid for years has created a lot of whiners. I bet many of you curse the rain and then complain that the sun's too hot.
 






Anonymous said:
Benefits:

Did anyone read through the benefits carefully and find the STD and LTD benefits bizarre? I've never paid attention to it in the past because I have not needed it and it was free. The way it reads is that you are charged for it here if you want your salary to be protected, otherwise you will be left without income if something happens to you like an accident or something??? Someone please help me understand this?? It also reads like you must be there for a year to have income "protection." Really?
Click to expand...

STD benefit looks essential based on the managers I met in Dallas
 
























Anonymous said:
Regeneron stock closed at 488.87 on Friday. You receive 500 options valued at $244,435. You have the option to buy it at that price in 4 years. Let's say the stock increases by 10% and is now valued at $537.757 per share. You are in the money and you exercise your options and sell. You sell them for $268,878.50. That's a gross profit of $24,443.50. Then you have to deduct capital gains tax (20%) and that leaves you with $19,554.80 You also will have transaction fees to pay as well.
Here's where the value of working for a company with a high stock price comes in. Let's say the stock price was at $170 on Friday instead (which is where Amgen's stock price is). 500 shares are valued at $85,000. The stock increases in value by 10% over four years and the new price is $187. Your are in the money. You exercise your options for $93,500 and your gross profit is $8,500. Your Regeneron stock options' gross profit is 287% higher than if you worked for Amgen and they issued the same number of stock options to you!!
Click to expand...

The difference is that Amgen, for all of its flaws, according to my friends there doesn't issue options, they issue shares of stock, so Amgen wins hands down. Options are a gamble that rarely payoff- especially when the options are WAY overpriced.

You have been duped.
 












Anonymous said:
The difference is that Amgen, for all of its flaws, according to my friends there doesn't issue options, they issue shares of stock, so Amgen wins hands down. Options are a gamble that rarely payoff- especially when the options are WAY overpriced.

You have been duped.
Click to expand...

Not so fast slick. Amgen reps got about $3500 in stock this year that will vest in 4 years. I'll gamble on the options here.
 












Anonymous said:
What a joke options vesting day is June 12th? Stock has gone up 100$ This year and if the launch isn't a success we will be under water on the options!
Click to expand...

Well you're not getting rich with options by joining an established company who's stock is at 500 you idiot! Grow some balls and join a start up rather than jump on the bandwagon 10 years to late than bitch that you don't make enough from the stock.. What the hell did u do to deserve anything? Go work for a company who's stock is under ten bucks and work to build sow thing
 






Anonymous said:
Well you're not getting rich with options by joining an established company who's stock is at 500 you idiot! Grow some balls and join a start up rather than jump on the bandwagon 10 years to late than bitch that you don't make enough from the stock.. What the hell did u do to deserve anything? Go work for a company who's stock is under ten bucks and work to build sow thing
Click to expand...

Exactly. Well said. Typical pharma rep.
 






Typical douchebag! What are you a "biotech rep" let me guess you're one of the specialty drug experts. You sell a pharmaceutical product you arrogant prick, and the rest will laugh as you will be at the bottom of the rankings, in case you haven't noticed no one likes you.
Btw ouch on today's stock increase, doesn't help June 12th out one bit.
 






Wise up people. I saw some good perspective in previous threads: A) The run is over (at least the run based on PCSK9) REGN is now in the "buy on rumor, sell on fact" phase. Anyone ever heard of that? It's a very common expression. REGN is selling at a whopping 160 times earnings. They have to KILL IT with PCSK9 for this to hold up. The whole category is going to disappoint in the short term. Uptake will be very slow. This stock will see <400 in the next year. If the whole market corrects this summer, a stock this overvalued will lead the pack. Been investing in Biotechs back to early DNA (Genentech's former trading symbol, AMGN when it was a darling of Wall street, Biogen, Medimmune, Sepracor, Idec, ALXN, you name it, I might have owned it. Go back to 1993 and look at AMGN stock. Company was growing 25% QUARTER OVER QUARTER and that year the stock went from 90 something (after several splits) to 30 by the summer. Why? It was trading at 120X earning when the market corrected. If you didn't get into REGN as an employee early you will not see the "biotech millionaire" label on your REGN stock portfolio. Still a very good company though. Their science platform is exceptional and worth watching for a good buy in point when the correction does happen. Thanks for letting me blather. I'll be waiting patiently for insulting replies.
 






Anonymous said:
Wise up people. I saw some good perspective in previous threads: A) The run is over (at least the run based on PCSK9) REGN is now in the "buy on rumor, sell on fact" phase. Anyone ever heard of that? It's a very common expression. REGN is selling at a whopping 160 times earnings. They have to KILL IT with PCSK9 for this to hold up. The whole category is going to disappoint in the short term. Uptake will be very slow. This stock will see <400 in the next year. If the whole market corrects this summer, a stock this overvalued will lead the pack. Been investing in Biotechs back to early DNA (Genentech's former trading symbol, AMGN when it was a darling of Wall street, Biogen, Medimmune, Sepracor, Idec, ALXN, you name it, I might have owned it. Go back to 1993 and look at AMGN stock. Company was growing 25% QUARTER OVER QUARTER and that year the stock went from 90 something (after several splits) to 30 by the summer. Why? It was trading at 120X earning when the market corrected. If you didn't get into REGN as an employee early you will not see the "biotech millionaire" label on your REGN stock portfolio. Still a very good company though. Their science platform is exceptional and worth watching for a good buy in point when the correction does happen. Thanks for letting me blather. I'll be waiting patiently for insulting replies.
Click to expand...

That's a solid post. Very good insight really and you're probably right. And I work here.
 






Top Bottom
Back
Quote